Company / Current Liabilities per Share
Travere Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.83
FY2025
5-year range
$1.83 / $2.77
FY2021-FY2025
Trend
-31.4%
vs FY2024
Sector context
#72 of 210
Health Care
What the data says
At $1.83, Travere Therapeutics, Inc.'s current liabilities per share ranks #139 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $1.83 in FY2025 to $2.77 in FY2023.
Based on SEC 10-K filings.
1.83 in FY2025 with a 5-year CAGR of -3.2%.
Improved from $2.77 to $1.83 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -7.0%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
-92.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 31.4% year-over-year.
- Ranks #72 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.83 | -31.4% |
| FY2024 | $2.66 | -3.7% |
| FY2023 | $2.77 | +21.6% |
| FY2022 | $2.27 | -4.2% |
| FY2021 | $2.37 | +10.4% |
| FY2020 | $2.15 | -6.8% |
| FY2019 | $2.31 | -13.2% |
| FY2018 | $2.66 | +17.6% |
| FY2017 | $2.26 | -1.0% |
| FY2016 | $2.28 | -31.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026